Brain Cancer Trial, Recruiting NCT06501521 Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic Condition: Brain Cancer
Back to Brain Cancer

Brain Cancer Trial, Recruiting

NCT06501521
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are adults (18 years or older)
  • People who have been diagnosed with a brain tumor

Who may not be able to join:

  • People who have another type of cancer in addition to a brain tumor
  • People who have an inflammatory disease (confirm with trial site for which specific conditions this includes)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Marian Hajduch, MD,PhD, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic

Phone: +420585632137

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
The Institute of Molecular and Translational Medicine, Czech Republic
Registry
ClinicalTrials.gov
Start date
1 January 2020
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇿 Czechia

Primary endpoints

Proteomic profiles of proximal liquids in brain tumor patients; Circulating tumor cells (CTCs) for non-invasive monitoring of GBM patients.; Extracellular vesicles (EVs) for non-invasive monitoring of GBM patients.; Urine as a source of GBM-specific nucleic acids fragments for disease monitoring.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov